Magnetic Resonance Imaging of the Lung: Oncological Applications

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorFondazione IRCCS Policlinico San Matteo di Pavia

About this trial

Lung neoplasms are characterized by a complex interaction between tumor cells and a variety of resident and infiltrating host elements, secreted factors, and extracellular matrix proteins, collectively referred to as the microenvironment. Nowadays, in the setting of lung cancer, and in particular non-small cell lung cancer (NSCLC), the evaluation of microenvironment characteristics can only be performed by a pathologist and only on histological material. By combining different MRI parameters, it may be possible to create a specific imaging "signature" for the three different immune phenotypes and thus be able to make a distinction based on MRI examination.

Eligibility criteria

Qualifiers

Primary NSCLC of the lung (TNM 8th edition T parameter ≥T1c)

Biopsy examination of the primary tumor adequate at least for PDL-1 quantification

Staging CT scan with uncertain N parameter and definite M parameter.

Disqualifiers

Absolute contraindications to magnetic resonance imaging or the administration of gadolinium-based contrast agents

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed

Locations

1
Fondazione IRCCS Policlinico San Matteo27100, Pavia Italy

Sponsors and collaborators

Fondazione IRCCS Policlinico San Matteo di Pavia

Lead sponsor